COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,237 Articles (22,733 medRxiv, 8,504 bioRxiv)

Most recent first Previous |  Page 426: Articles 4251-4260  | Next

SARS-CoV-2 specific cellular and humoral immunity after bivalent BA.4/5 COVID-19 vaccination in previously infected and non-infected individuals
Urschel, R., Bronder, S., Klemis, V., Marx, S., Hielscher, F., Abu-Omar, A., Guckelmus, C., Schneitler, S., Baum, C., Becker, S. L., Gaertner, B. C., Sester, U., Widera, M., Schmidt, T., Sester, M.
10.1101/2023.05.03.23289472 — Posted: 2023-05-05
Persistent immune abnormalities discriminate post-COVID syndrome from convalescence
Sbierski-Kind, J., Schlickeiser, S., Feldmann, S., Ober, V., Gruener, E., Pleimelding, C., Gilberg, L., Brand, I., Weigl, N., Ahmed, M. I. M., Ibarra, G., Ruzicka, M., Benesch, C., Pernpruner, A., Valdinoci, E., Hoelscher, M., Adorjan, K., Stubbe, H. C., Pritsch, M., Seybold, U., Bogner, J., Roider, J.
10.1101/2023.05.02.23289345 — Posted: 2023-05-05
Improved access to diabetic retinopathy screening through primary care-based teleophthalmology during the COVID-19 pandemic
Chen, K., Dow, E., Basina, M., Dang, J., Khan, N., Kim, M., Levine, M. L., Mishra, K., Perera, C., Phadke, A., Tan, M., Weng, K., Do, D., Mahajan, V. B., Mruthyunjaya, P., Leng, T., Myung, D.
10.1101/2023.05.03.23289435 — Posted: 2023-05-05
COVID-19 risk variant associations with chromatin remodelling, DNA maintenance and surfactant genes are infection dependent in the lung
Jaros, R. K., Golovina, E., O'Sullivan, J. M.
10.1101/2023.05.03.23289478 — Posted: 2023-05-05
Mode Connections For Clinical Incremental Learning: Lessons From The COVID-19 Pandemic
Thakur, A., Wang, C., Certili, T., Eyre, D. W., Clifton, D.
10.1101/2023.05.05.23289583 — Posted: 2023-05-05
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
Roessler, A., Netzl, A., Knabl, L., Bante, D., Wilks, S. H., Borena, W., von Laer, D., Smith, D. J., Kimpel, J.
10.1101/2023.05.02.23289412 — Posted: 2023-05-05
Receipt of anti-SARS-CoV-2 pharmacotherapies among non-hospitalized U.S. Veterans with COVID-19, January 2022 to January 2023
Yan, L., Streja, E., Li, Y., Rajeevan, N., Rowneki, M., Berry, K., Hynes, D. M., Cunningham, F., Huang, G. D., Aslan, M., Ioannou, G. N., Bajema, K. L.
10.1101/2023.05.03.23289479 — Posted: 2023-05-05
Excess Mortality Resulting from COVID-19 in Turkey during 2020-2021: Regional and Time-Based Analysis
Keskin, S., Ergor, G.
10.1101/2023.05.04.23289498 — Posted: 2023-05-05
The plasma metabolome of long COVID-19 patients two years after infection
Lopez-Hernandez, Y., Monarrez-Aquino, J., Garcia-Lopez, D. A., Zheng, J., Borrego, J. C., Torres-Calzada, C., Elizalde-Diaz, J. P., Mandal, R., Berjanskii, M., Martinez-Martinez, E., Lopez, J. A., Wishart, D. S.
10.1101/2023.05.03.23289456 — Posted: 2023-05-05
COVID-19 Infection Is Associated with Poor Outcomes in Patients with Intracerebral Hemorrhage
Renedo, D. B., Leasure, A. C., Young, R., Rivier, C., Alhanti, B., Mac Grory, B., Messe, S. R., Reeves, M. J., Hassan, A. E., Schwamm, L. H., de Havenon, A., Matouk, C. C., Sheth, K. N., Falcone, G. J.
10.1101/2023.05.03.23289488 — Posted: 2023-05-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).